In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Multimodality imaging for stratifying prognosis of sudden cardiac death (SCD)



In Athletes (A. La Gerche)

Sudden cardiac death (SCD) is uncommon but dramatic in athletes. Cardiomyopathies (mainly hypertrophic cardiomyopathy, HCM) are the main cause of SCD in young athletes, and coronary artery disease in the older athletes. Diagnosis is difficult in athletes. Exercise capacity is not enough to exclude cardiomyopathies, but cardiac imaging evaluation can be extremely useful.

In Hypertrophic cardiomyopathies (S. Nagueh)

Multi-modality imaging is very important to predict SCD in HCM. Main risk factors include maximal wall thickness ≥30 mm, low ejection fraction (EF) and Global Longitudinal Strain (GLS), diastolic septum E/e’ dysfunction, left ventricular output tract (LVOT) obstruction(also provoked by exercise), late gadolinium enhancement (scar, presence and extent) and inducible myocardial ischemia.

In valvular heart disease(I A. Sebag)

LVEF and aortic end systolic diameter are important but questionable. GLS (>-15%) can provide important additional information in patients with normal LVEF. The rate of progression of aortic jet velocity (which is incremental to the extent of valve calcification), left ventricular hypertrophy and inappropriate increase of left ventricular mass as well as myocardial fibrosis are predictive factors in aortic stenosis. GLS , low contractile reserve and myocardial fibrosis predict cardiac events also in mitral regurgitation.

In Ischemic cardiomyopathy (T. Edvarsen)

CAD is the main cause of ischemic cardiomyopathy in patients older than 35 years. LVEF alone is often used in these patients to assess long-term outcomes and the risk of SCD and pump failure, and is used to select patients for device therapy (ICD and CRT). However, LVEF has shortcomings due to variability of measurements and risk prediction on an individual basis. Myocardial scar, GLS (>-14%) and mechanical dispersion, derived from GLS, have proven incremental prognostic value over LVEF alone for predicting severe arrhythmias and SCD.

The content of this article reflects the personal opinion of the author/s and is not necessarily the official position of the European Society of Cardiology.